GGrantIndex
← Leaderboards

Timothy Charles Rodwell

University Of California, San Diego

$12,115,545
Attributed
$17,644,596
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,644,596 · 9

By mechanism

R01$15,664,294 · 5
R56$754,249 · 1
R21$738,973 · 2
K01$487,080 · 1

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Specificity

Research focus

SpecificityPerformanceSamplingMycobacterium TuberculosisTuberculosisWorld Health OrganizationDiagnosisSputumDetectionTransmission ProcessCharacteristicsPharmaceutical PreparationsDrug Resistance In TuberculosisLaboratoriesProspectiveSensitivity And SpecificityCaliforniaProteinsBloodBaseTranslatingChildBiological MarkersDrug Resistance

Grant awards (27)

Automated Sequencing for Culture-free Diagnosis of Drug Resistant TB$727,384
R01 · FY2025 · AI · contact PI
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR$718,939
R01 · FY2025 · AI · contact PI
A Novel Electrochemical LFA for Diagnosing TB from a Single Drop of Blood$238,500
R21 · FY2025 · AI · contact PI
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR$739,826
R01 · FY2024 · AI · contact PI
Automated Sequencing for Culture-free Diagnosis of Drug Resistant TB$728,822
R01 · FY2024 · AI · contact PI
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR$795,192
R01 · FY2023 · AI · contact PI
Automated Sequencing for Culture-free Diagnosis of Drug Resistant TB$764,235
R01 · FY2023 · AI · contact PI
An Antigen-Detection Blood Test for Pulmonary Tuberculosis$728,243
R01 · FY2023 · AI
A Novel Point-of-Care Assay for Diagnosing TB from Blood using Exosomes$754,249
R56 · FY2022 · AI · contact PI
Identifying individuals at risk of progression to active tuberculosis$742,137
R01 · FY2022 · AI
An Antigen-Detection Blood Test for Pulmonary Tuberculosis$736,330
R01 · FY2022 · AI
An Antigen-Detection Blood Test for Pulmonary Tuberculosis$736,404
R01 · FY2021 · AI
Identifying individuals at risk of progression to active tuberculosis$728,879
R01 · FY2021 · AI
Identifying individuals at risk of progression to active tuberculosis$711,592
R01 · FY2020 · AI
An Antigen-Detection Blood Test for Pulmonary Tuberculosis$694,190
R01 · FY2020 · AI
An Antigen-Detection Blood Test for Pulmonary Tuberculosis$751,680
R01 · FY2019 · AI
Culture-free next generation sequencing for rapid detection of drug-resistant tuberculosis$216,688
R21 · FY2019 · AI · contact PI
An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples$953,173
R01 · FY2018 · AI · contact PI
Culture-free next generation sequencing for rapid detection of drug-resistant tuberculosis$283,785
R21 · FY2018 · AI · contact PI
An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples$984,516
R01 · FY2017 · AI · contact PI
An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples$1,010,275
R01 · FY2016 · AI · contact PI
An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples$1,047,769
R01 · FY2015 · AI · contact PI
An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples$1,364,708
R01 · FY2014 · AI · contact PI
Binational Transmission of Multidrug-Resistant Tuberculosis, California & Mexico$121,770
K01 · FY2012 · AI · contact PI
Binational Transmission of Multidrug-Resistant Tuberculosis, California & Mexico$121,770
K01 · FY2011 · AI · contact PI
Binational Transmission of Multidrug-Resistant Tuberculosis, California & Mexico$121,770
K01 · FY2010 · AI · contact PI
Binational Transmission of Multidrug-Resistant Tuberculosis, California & Mexico$121,770
K01 · FY2009 · AI · contact PI